Correlation Between LQwD FinTech and Big Pharma
Can any of the company-specific risk be diversified away by investing in both LQwD FinTech and Big Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LQwD FinTech and Big Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LQwD FinTech Corp and Big Pharma Split, you can compare the effects of market volatilities on LQwD FinTech and Big Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LQwD FinTech with a short position of Big Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of LQwD FinTech and Big Pharma.
Diversification Opportunities for LQwD FinTech and Big Pharma
-0.95 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between LQwD and Big is -0.95. Overlapping area represents the amount of risk that can be diversified away by holding LQwD FinTech Corp and Big Pharma Split in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Big Pharma Split and LQwD FinTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LQwD FinTech Corp are associated (or correlated) with Big Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Big Pharma Split has no effect on the direction of LQwD FinTech i.e., LQwD FinTech and Big Pharma go up and down completely randomly.
Pair Corralation between LQwD FinTech and Big Pharma
Assuming the 90 days trading horizon LQwD FinTech Corp is expected to generate 6.32 times more return on investment than Big Pharma. However, LQwD FinTech is 6.32 times more volatile than Big Pharma Split. It trades about 0.07 of its potential returns per unit of risk. Big Pharma Split is currently generating about 0.01 per unit of risk. If you would invest 49.00 in LQwD FinTech Corp on September 2, 2024 and sell it today you would earn a total of 101.00 from holding LQwD FinTech Corp or generate 206.12% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
LQwD FinTech Corp vs. Big Pharma Split
Performance |
| Timeline |
| LQwD FinTech Corp |
| Big Pharma Split |
LQwD FinTech and Big Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with LQwD FinTech and Big Pharma
The main advantage of trading using opposite LQwD FinTech and Big Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LQwD FinTech position performs unexpectedly, Big Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Big Pharma will offset losses from the drop in Big Pharma's long position.The idea behind LQwD FinTech Corp and Big Pharma Split pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Big Pharma vs. NovaGold Resources | Big Pharma vs. HPQ Silicon Resources | Big Pharma vs. Eastwood Bio Medical Canada | Big Pharma vs. Diamond Fields Resources |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |